IMNN · Imunon, Inc.
$1.53
+0.01 (+0.33%)
At close · Jul 27
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such conditions raise substantial doubts about the Company's ability to continue as a going concern. Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$6.35M
Shares
4.20M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Stacy Lindborg | CEO | $1,029,349 |
| Michael Tardugno | CEO | $605,899 |
| Douglas Faller | Chief Medical Officer | $589,810 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Stacy Lindborg | CEO | $1,189,339 |
| Jeffrey Church | CFO | $807,987 |
| Khursheed Anwer | Chief Science Officer | $741,680 |
| Michael Tardugno | CEO | $734,810 |
| David Gaiero | CFO | $280,000 |
| Corinne Le Goff | CEO | $148,869 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Corinne Le Goff | CEO | $1,055,814 |
| Khursheed Anwer | Chief Science Officer | $680,159 |
| Jeffrey Church | CFO | $679,922 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael Tardugno | Chairman | $2,085,391 |
| Corinne Le Goff | CEO | $883,794 |
| Nicholas Borys | Executive Vice President and Chief Medical Officer | $707,122 |
| Khursheed Anwer | Chief Science Officer | $678,658 |
| Jeffrey Church | CFO | $636,631 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Tardugno | Chairman | $2,312,625 |
| Jeffrey Church | CFO | $1,087,963 |
| Khursheed Anwer | Chief Science Officer | $1,020,478 |
| Nicholas Borys | Executive Vice President and Chief Medical Officer | $789,947 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Tardugno | CEO | $1,429,073 |
| Nicholas Borys | Executive Vice President and Chief Medical Officer | $756,042 |
| Jeffrey Church | CFO | $696,423 |
| Khursheed Anwer | Chief Science Officer | $643,848 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Michael Tardugno | CEO | $1,251,640 |
| Nicholas Borys | Executive Vice President and Chief Medical Officer | $700,708 |
| Khursheed Anwer | Chief Science Officer | $650,698 |
| Jeffrey Church | CFO | $647,167 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Michael Tardugno | CEO | $2,950,091 |
| Nicholas Borys | Executive Vice President and Chief Medical Officer | $1,155,246 |
| Jeffrey Church | CFO | $1,126,392 |
| Khursheed Anwer | Chief Science Officer | $666,642 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Josh Blacher | interim Chief Financial Officer | Appointed | 2026-06-30 |
| Jeffrey Church | interim Chief Financial Officer | Retired | 2026-06-30 |